Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis.

McLaughlin, Rene J; Spindler, Matthew P; van Lummel, Menno; Roep, Bart O

McLaughlin, Rene J; Spindler, Matthew P; van Lummel, Menno; Roep, Bart O.

Afiliação

McLaughlin RJ; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, E3-Q, PO Box 9600, 2300 RC, Leiden, The Netherlands.
Spindler MP; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, E3-Q, PO Box 9600, 2300 RC, Leiden, The Netherlands.
van Lummel M; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, E3-Q, PO Box 9600, 2300 RC, Leiden, The Netherlands.
Roep BO; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, E3-Q, PO Box 9600, 2300 RC, Leiden, The Netherlands. boroep@lumc.nl.

Curr Diab Rep ; 16(7): 63, 2016 07.

Article em En | MEDLINE | ID: mdl-27168063

Assuntos

Diabetes Mellitus Tipo 1/metabolismo; Processamento de Proteína Pós-Traducional; Animais; Autoimunidade; Diabetes Mellitus Tipo 1/imunologia; Antígenos de Histocompatibilidade Classe I/imunologia; Humanos; Ilhotas Pancreáticas/imunologia; Ilhotas Pancreáticas/metabolismo; Fatores de Risco

Palavras-chave

Autoimmune disease; High-risk HLA; Islet antigens; Posttranslational modification; Type 1 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Processamento de Proteína Pós-Traducional / Diabetes Mellitus Tipo 1 Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google